Literature DB >> 20378778

Cancer therapy reform.

Arthur D Levinson.   

Abstract

Mesh：

Year:  2010        PMID： 20378778     DOI： 10.1126/science.1189749

Source DB:  PubMed          Journal:  Science        ISSN： 0036-8075            Impact factor:   47.728


× No keyword cloud information.
  13 in total

1.  Complete eradication of xenograft hepatoma by oncolytic adenovirus ZD55 harboring TRAIL-IETD-Smac gene with broad antitumor effect.

Authors:  Shi-Bing Wang; Yuan Tan; Wen Lei; Yi-Gang Wang; Xiu-Mei Zhou; Xiao-Yuan Jia; Kang-Jian Zhang; Liang Chu; Xin-Yuan Liu; Wen-Bin Qian
Journal:  Hum Gene Ther       Date:  2012-07-20       Impact factor: 5.695

2.  Opportunities and challenges in the development of experimental drug combinations for cancer.

Authors:  Rachel W Humphrey; Laura M Brockway-Lunardi; David T Bonk; Kathleen M Dohoney; James H Doroshow; Sandra J Meech; Mark J Ratain; Suzanne L Topalian; Drew M Pardoll
Journal:  J Natl Cancer Inst       Date:  2011-07-15       Impact factor: 13.506

3.  Identification of putative actionable alterations in clinically relevant genes in breast cancer.

Authors:  Pushpinder Kaur; Tania B Porras; Anthony Colombo; Alexander Ring; Janice Lu; Irene Kang; Julie E Lang
Journal:  Br J Cancer       Date:  2021-08-28       Impact factor: 9.075

Review 4.  Design and Challenges of Sonodynamic Therapy System for Cancer Theranostics: From Equipment to Sensitizers.

Authors:  Zhuoran Gong; Zhifei Dai
Journal:  Adv Sci (Weinh)       Date:  2021-03-12       Impact factor: 16.806

Review 5.  Excess costs of comorbidities in chronic obstructive pulmonary disease: a systematic review.

Authors:  Manuel B Huber; Margarethe E Wacker; Claus F Vogelmeier; Reiner Leidl
Journal:  PLoS One       Date:  2015-04-13       Impact factor: 3.240

6.  Synergistic antitumor effects of CDK inhibitor SNS‑032 and an oncolytic adenovirus co‑expressing TRAIL and Smac in pancreatic cancer.

Authors:  Yun Ge; Wen Lei; Yingyu Ma; Yigang Wang; Buyun Wei; Xiaoyi Chen; Guoqing Ru; Xianglei He; Xiaozhou Mou; Shibing Wang
Journal:  Mol Med Rep       Date:  2017-04-12       Impact factor: 2.952

7.  Natural formulas and the nature of formulas: Exploring potential therapeutic targets based on traditional Chinese herbal formulas.

Authors:  Qianru Zhang; Hua Yu; Jin Qi; Daisheng Tang; Xiaojia Chen; Jian-Bo Wan; Peng Li; Hao Hu; Yi-Tao Wang; Yuanjia Hu
Journal:  PLoS One       Date:  2017-02-09       Impact factor: 3.240

8.  ASDCD: antifungal synergistic drug combination database.

Authors:  Xing Chen; Biao Ren; Ming Chen; Ming-Xi Liu; Wei Ren; Quan-Xin Wang; Li-Xin Zhang; Gui-Ying Yan
Journal:  PLoS One       Date:  2014-01-24       Impact factor: 3.240

9.  Molecular targets of Chinese herbs: a clinical study of hepatoma based on network pharmacology.

Authors:  Li Gao; Xiao-Dong Wang; Yang-Yang Niu; Dan-Dan Duan; Xue Yang; Jian Hao; Cui-Hong Zhu; Dan Chen; Ke-Xin Wang; Xue-Mei Qin; Xiong-Zhi Wu
Journal:  Sci Rep       Date:  2016-05-04       Impact factor: 4.379

10.  Synergistic Anti-tumour Effects of Quercetin and Oncolytic Adenovirus expressing TRAIL in Human Hepatocellular Carcinoma.

Authors:  Hai Zou; Yong-Fa Zheng; Wei Ge; Shi-Bing Wang; Xiao-Zhou Mou
Journal:  Sci Rep       Date:  2018-02-01       Impact factor: 4.379
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.